Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00668213 · ClinicalTrials.gov registry record

Antioxidant Systems and Age-Related Macular Degeneration

A clinical trial, sponsored by Vanderbilt University.

Completed
Registry status
143
Enrollment target

NCT00668213: Completed study, sponsored by Vanderbilt University.

NCT00668213 is a clinical trial that has completed, run by Vanderbilt University. The registered enrollment target is 143 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00668213 has completed, sponsored by Vanderbilt University.

COMPLETED
Registry status
143 participants
Enrollment target

Study Summary

Objective: The objective of this study was to determine whether the antioxidant supplements used in AREDS shifted the plasma pool of the AREDS subjects to a more reduced state. The AREDS subjects were randomly assigned to one of four treatment groups: 1. antioxidants (500mg Vitamin C, 4000IU Vitamin E, 15mg beta carotene) 2. zinc (80mg zinc oxide, 2mg cupric oxide) 3. antioxidants plus zinc; 4. placebo. None of the subjects received supplemental GSH or cyst (e) ine. Age-related macular degeneration (AMD) is the leading cause of severe visual impairment in elderly Americans, with an estimated 15 million people having some form of this disease. AMD primarily affects the central vision and many patients develop severe visual handicaps. Currently there are no clear established understandings of the etiology or pathogenesis of this disease.

Trial Details

FieldValue
Enrollment Target 143 participants
Start Date 2006-06
Est. Completion 2010-06
Vanderbilt University

430 total trials

What the finished NCT00668213 record still lists

NCT00668213 is an observational study that tracks outcomes without assigning an intervention. The registered 143 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00668213 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00668213 about?

NCT00668213 is a clinical study titled "Antioxidant Systems and Age-Related Macular Degeneration". Objective: The objective of this study was to determine whether the antioxidant supplements used in AREDS shifted the plasma pool of the AREDS subjects to a more reduced state. The AREDS subjects were randomly assigned to one of four treatment groups: 1. antioxidants (500mg Vitamin C, 4000IU Vitam...

What is the current status of trial NCT00668213?

This trial is currently completed. The enrollment target is 143 participants. The study started on 2006-06. Estimated completion is 2010-06.

Who is sponsoring clinical trial NCT00668213?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01861106 · 144 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations

  • NCT03482245 · 144 participants · NA

    The Role of Circadian Clock Proteins in Innate and Adaptive Immunity

  • NCT03504683 · 144 participants · NA

    MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes

  • NCT03905603 · 144 participants · Early Phase 1

    Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00668213, the US trial registry maintained by the National Library of Medicine. NCT00668213 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.